Cargando…
Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer
Over the past decades, a large amount of data has been accumulated in various subfields of glycobiology. However, much clinically relevant data and many tools are still not widely used in medicine. Synthetic glycoconjugates with the known structure of glycans are an accurate tool for the study of gl...
Autor principal: | Smorodin, Eugeniy P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584091/ https://www.ncbi.nlm.nih.gov/pubmed/34769037 http://dx.doi.org/10.3390/ijms222111608 |
Ejemplares similares
-
The Relation of the Level of Serum Anti-TF, -Tn and -Alpha-Gal IgG to Survival in Gastrointestinal Cancer Patients
por: Smorodin, Eugeniy, et al.
Publicado: (2013) -
IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
por: Smorodin, Eugeniy, et al.
Publicado: (2018) -
Glycan profiling of the gut microbiota by Glycan-seq
por: Oinam, Lalhaba, et al.
Publicado: (2022) -
Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients
por: Pochechueva, Tatiana, et al.
Publicado: (2016) -
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies
por: Ziganshina, Marina M., et al.
Publicado: (2023)